Viewing Study NCT02925104


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-02-20 @ 8:08 PM
Study NCT ID: NCT02925104
Status: COMPLETED
Last Update Posted: 2020-12-19
First Post: 2016-10-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study to Assess PK, Safety and Tolerability of INC280 When Taken With Food in cMET Dysregulated Advanced Solid Tumors.
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CINC280A2108
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators